Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
EchoIQ Limited ( (AU:EIQ) ) has shared an update.
Echo IQ Limited has secured a reseller agreement with SARC MedIQ, a leading US-based provider of imaging workflow solutions, to expand the use of its EchoSolv AS technology across the United States. This agreement will allow Echo IQ to access SARC MedIQ’s extensive network of over 300 healthcare facilities and clinics, significantly reducing sales and distribution costs while accelerating market access. The collaboration is expected to provide a predictable revenue stream and enhance the company’s positioning in the US market by improving detection rates for severe Aortic Stenosis.
The most recent analyst rating on (AU:EIQ) stock is a Buy with a A$0.38 price target. To see the full list of analyst forecasts on EchoIQ Limited stock, see the AU:EIQ Stock Forecast page.
More about EchoIQ Limited
Echo IQ Limited is an AI and medical technology company based in Sydney, Australia, specializing in AI-driven technology and proprietary software to enhance decision-making in cardiology.
Average Trading Volume: 2,918,942
Technical Sentiment Signal: Hold
Current Market Cap: A$161.3M
For a thorough assessment of EIQ stock, go to TipRanks’ Stock Analysis page.